133 STAT. 964  PUBLIC LAW 116–22—JUNE 24, 2019  Effective date.  (B) as of the date of the enactment of this Act, remains  in the care of the Department of Health and Human Serv- ices; and  (C) can be safely reunited with such parent or  guardian; and  (2) a report on challenges and deficiencies related to the  oversight of, and care for, unaccompanied alien children and  appropriately reuniting such children with their parents or  guardians, and the actions taken to address any challenges  and deficiencies related to unaccompanied alien children in  the custody of the Department of Health and Human Services,  including deficiencies identified and publicly reported by Con- gress, the Government Accountability Office, or the inspectors  general of the Department of Health and Human Services  or other Federal departments.  (a) PUBLIC HEALTH SERVICE ACT.—Title III (42 U.S.C. 241  et seq.) is amended—  (1) in paragraphs (1) and (5) of section 319F–1(a) (42 U.S.C.  247d–6a(a)), by striking ‘‘section 319F(h)’’ each place such term  appears and inserting ‘‘section 319F(e)’’; and  (2) in section 319K(a) (42 U.S.C. 247d–7d(a)), by striking  ‘‘section 319F(h)(4)’’ and inserting ‘‘section 319F(e)(4)’’.  (b) PUBLIC HEALTH SECURITY GRANTS.—Section 319C–1(b)(2)  (42 U.S.C. 247d–3a(b)(2)) is amended—  (1) in subparagraph (C), by striking ‘‘individuals,,’’ and  inserting ‘‘individuals,’’; and  (2) in subparagraph (F), by striking ‘‘make satisfactory  annual improvement and describe’’ and inserting ‘‘makes satis- factory annual improvement and describes’’.  (c) EMERGENCY USE INSTRUCTIONS.—Subparagraph (A) of sec- tion 564A(e)(2) of the Federal Food, Drug, and Cosmetic Act (21  U.S.C. 360bbb–3a(e)(2)) is amended by striking ‘‘subsection  (a)(1)(C)(i)’’ and inserting ‘‘subsection (a)(1)(C)’’.  (d) PRODUCTS HELD FOR EMERGENCY USE.—Section 564B(2)  of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–  3b) is amended—  (1) in subparagraph (B), by inserting a comma after ‘‘505’’;  and  (2) in subparagraph (C), by inserting ‘‘or section 564A’’  before the period at the end.  (e) TRANSPARENCY.—Section 507(c)(3) of the Federal Food,  Drug, and Cosmetic Act (21 U.S.C. 357(c)(3)) is amended—  (1) by striking ‘‘Nothing in’’ and inserting the following:  ‘‘(A) IN GENERAL.—Nothing in’’;  (2) by inserting ‘‘or directing’’ after ‘‘authorizing’’;  (3) by striking ‘‘disclose any’’ and inserting ‘‘disclose—  ‘‘(i) any’’;  (4) by striking the period and inserting ‘‘; or’’; and  (5) by adding at the end the following:  ‘‘(ii) in the case of a drug development tool that  may be used to support the development of a qualified  countermeasure, security countermeasure, or qualified  pandemic or epidemic product, as defined in sections  319F–1, 319F–2, and 319F–3, respectively, of the  Public Health Service Act, any information that the  SEC. 705. TECHNICAL AMENDMENTS. 